Form 4: Henry Schein EVP Sells Shares, Gifts to Family Trusts

Henry Schein's EVP, Chief Strategic Officer, Mark E. Mlotek, reported sales of common stock and gifts to family trusts totaling over 7,400 shares.

Summary

• Mark E. Mlotek, EVP, Chief Strategic Officer of Henry Schein, Inc. (HSIC), reported multiple transactions involving the company's common stock.
• On March 4, 2026, Mlotek sold 4,100 shares at $80.795 per share and an additional 1,825 shares at $80.811 per share.
• On March 5, 2026, Mlotek gifted 1,215 shares, reflecting a transfer of 900 shares to trusts for the benefit of family members.
• On March 6, 2026, Mlotek gifted 300 shares, reflecting a transfer of 600 shares to trusts for the benefit of family members.
• Following these transactions, Mlotek directly beneficially owns 77,539 shares.
• Indirect beneficial ownership includes 7,416 shares as trustee of family trusts (which includes the 1,500 shares transferred on March 5 and 6) and 4,085 shares through a 401(k) plan.
• The transactions were made pursuant to a Rule 10b5-1(c) plan.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly negative event. While sales by an executive can be a minor negative signal, the use of a 10b5-1 plan mitigates concerns about opportunistic selling, and the executive retains significant ownership.

Positives

• The transactions were executed under a Rule 10b5-1(c) plan, indicating pre-planned sales and reducing concerns about opportunistic insider selling.
• Mlotek retains significant direct and indirect beneficial ownership in Henry Schein, demonstrating continued alignment with shareholder interests.

Negatives

• The sale of 5,925 shares by a key executive could be perceived as a slight negative signal regarding the executive's immediate outlook on the stock.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider transactions, particularly sales, are closely watched by the market for signals about management's confidence. However, sales executed under a Rule 10b5-1 plan are generally viewed with less concern as they are pre-scheduled and not indicative of immediate market timing.

Comparison to Industry Standards

• Insider sales are a common occurrence across all industries, particularly for executives managing personal finances or diversifying portfolios.
• The use of Rule 10b5-1 plans is a standard practice among executives of publicly traded companies, such as those in the healthcare distribution sector like Patterson Companies Inc. (PDCO) or Dentsply Sirona Inc. (XRAY), to mitigate accusations of insider trading.
• The retained beneficial ownership of over 80,000 shares (direct and indirect) by a Chief Strategic Officer is a substantial holding, comparable to executive holdings in similar-sized companies, indicating continued vested interest.

Related Party Transactions

• Transfer of 1,500 shares to trusts for the benefit of family members where Mr. Mlotek is the trustee.

Stakeholder Impact

• Shareholders: May interpret the sales as a minor negative signal, but the 10b5-1 plan context and retained ownership soften the impact.
• Employees: No direct impact.
• Customers: No direct impact.
• Suppliers: No direct impact.
• Creditors: No direct impact.

Key Dates

Recommendation

The reported transactions are routine insider sales and gifts executed under a pre-arranged 10b5-1 plan. While sales by an executive are generally watched, these are not indicative of a change in the company's fundamental outlook or the executive's long-term confidence, especially given the significant remaining holdings. Therefore, the filing does not provide a strong basis for a change in investment recommendation.

Keywords

Henry Schein, HSIC, Insider Trading, Form 4, Stock Sale, Executive Compensation, Mark E. Mlotek, Rule 10b5-1, Common Stock, Beneficial Ownership